1. Home
  2. PI vs LEGN Comparison

PI vs LEGN Comparison

Compare PI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Impinj Inc.

PI

Impinj Inc.

HOLD

Current Price

$208.23

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$23.31

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PI
LEGN
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.9B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
PI
LEGN
Price
$208.23
$23.31
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$222.75
$69.33
AVG Volume (30 Days)
631.4K
2.1M
Earning Date
02-04-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$359,795,000.00
$909,045,000.00
Revenue This Year
$1.30
$68.52
Revenue Next Year
$22.70
$48.63
P/E Ratio
N/A
N/A
Revenue Growth
4.24
74.75
52 Week Low
$60.85
$20.21
52 Week High
$247.06
$45.30

Technical Indicators

Market Signals
Indicator
PI
LEGN
Relative Strength Index (RSI) 72.37 48.55
Support Level $168.86 $20.21
Resistance Level $182.16 $22.07
Average True Range (ATR) 9.74 0.84
MACD 4.39 0.42
Stochastic Oscillator 95.60 95.67

Price Performance

Historical Comparison
PI
LEGN

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: